6-Bromo-4-chloroquinoline
[CAS# 65340-70-7]

Identification

• Classification: Pharmaceutical intermediate >> Heterocyclic compound intermediate >> Quinoline compound
• Name: 6-Bromo-4-chloroquinoline
• Molecular Formula: C₉H₅BrClN
• Molecular Weight: 242.50
• CAS Registry Number: 65340-70-7
• EC Number: 833-852-4
• SMILES: C1=CC2=NC=CC(=C2C=C1Br)Cl

Properties

• Density: 1.7±0.1 g/cm³ Calc.^*
• Melting point: 110 - 112 ºC (Expl.)
• Boiling point: 314.6±22.0 ºC 760 mmHg (Calc.)^*
• Flash point: 144.1±22.3 ºC (Calc.)^*
• Index of refraction: 1.68 (Calc.)^*

^* Calculated using Advanced Chemistry Development (ACD/Labs) Software.

Safety Data

• Hazard Symbols: GHS06;GHS07 Danger
• Hazard Statements: H301-H302-H312-H315-H319-H332-H335
• Precautionary Statements: P261-P264-P264+P265-P270-P271-P280-P301+P316-P301+P317-P302+P352-P304+P340-P305+P351+P338-P317-P319-P321-P330-P332+P317-P337+P317-P362+P364-P403+P233-P405-P501

Hazard Classification

Hazard	Class	Category Code	Hazard Statement
Skin irritation	Skin Irrit.	2	H315
Eye irritation	Eye Irrit.	2A	H319
Eye irritation	Eye Irrit.	2	H319
Specific target organ toxicity - single exposure	STOT SE	3	H335
Acute toxicity	Acute Tox.	4	H332
Acute toxicity	Acute Tox.	4	H302
Acute toxicity	Acute Tox.	4	H312

Discovory and Applicatios

6-Bromo-4-chloroquinoline is a halogenated derivative of quinoline that has been adopted in research laboratories as a useful intermediate for the preparation of more complex nitrogen-containing heterocycles. It incorporates both bromine and chlorine substituents into the quinoline ring system, positioned in a manner that enables selective chemical transformations. This design allows the compound to serve as a modular platform in synthetic sequences where diversity and precise functional control are required. Because quinoline derivatives appear in many biologically active natural products and synthetic medicinal agents, halogenated analogs such as this compound have drawn interest for more than two decades.

The compound is usually obtained through the functional modification of a preexisting quinoline precursor. Established synthetic methods describe the electrophilic replacement of a hydroxyl or amino function on the quinoline core with chlorine, while retaining a bromine atom placed earlier in the sequence. The reaction is commonly performed with a chlorinating agent under elevated temperature, after which the product is isolated by standard extraction, purification, and crystallization procedures. The resulting material is typically obtained as a solid that can be stored in sealed containers at room temperature for extended periods when protected from moisture and light. In some laboratory reports, alternative starting materials have been used to reach the same target structure, including routes based on cyclization of substituted anilines that are further halogenated in later steps. These approaches reflect the adaptability of quinoline chemistry to different feedstocks and process requirements.

Research interest in 6-bromo-4-chloroquinoline comes primarily from its role as a synthetic intermediate. The presence of two halogens with different reactivities enables stepwise replacement through well established coupling and substitution reactions. In many synthetic plans, the bromine atom is targeted first in metal-catalyzed coupling reactions, while the chlorine atom remains available for a later transformation. In other cases, the chlorine atom undergoes nucleophilic aromatic substitution to introduce functional groups such as amines, alkoxides, or heterocycles, while the bromine atom is retained for subsequent elaboration. This strategic sequencing provides a controlled path toward densely functionalized quinoline derivatives. The compound has therefore become a convenient entry point into families of molecules that require multiple, spatially defined substituents on the heteroaromatic core.

The compound has also found application in medicinal chemistry research programs, where quinoline frameworks serve as a base structure for experimental agents. In these settings, 6-bromo-4-chloroquinoline is not generally used as a final active substance, but rather as a scaffold to construct other molecules that are then evaluated for biological properties. It has enabled the preparation of candidate inhibitors, ligands, and probes in various discovery programs. Its halogenated design is especially well suited for systematic structure modification, which is essential when researchers investigate the relationship between molecular structure and activity. Because of this utility, it is commercially available from several chemical suppliers in research quantities, facilitating its adoption in academic and industrial laboratories.

Outside of medicinal chemistry, the compound has been incorporated into exploratory materials research. Quinoline derivatives have been investigated for possible use in optical, coordination, and electronic applications, and halogenated building blocks like 6-bromo-4-chloroquinoline are sometimes used to construct the necessary extended structures. By introducing electron donating or electron withdrawing groups through the two halogen positions, researchers can tune the electronic properties of the resulting molecules. This type of controlled functionalization is a recurring theme in heterocyclic materials chemistry.

Although 6-bromo-4-chloroquinoline is not known as a natural product and does not itself have mainstream industrial uses, it has an established role as a versatile intermediate. Its significance lies in its ability to bridge fundamental heterocyclic chemistry and the practical needs of compound development. The continued interest in quinoline derivatives ensures that the compound remains relevant as a modular and adaptable starting point for the synthesis of complex molecules in multiple fields of research.

References

2012. Arylation of adamantanamines: IV. Palladium-catalyzed arylation of amines of adamantane series with isomeric chloroquinolines. Russian Journal of Organic Chemistry, 48(11).
DOI: 10.1134/s1070428012110012

2005. Successive substitution of halogen atoms in 4,6-dihaloquinolines in palladium-catalyzed reactions with amines and arylboronic acids. Russian Chemical Bulletin, 54(5).
DOI: 10.1007/s11172-005-0239-y

2003. Successive Replacement of Halogen Atoms in 4,6-Dihaloquinolines in Cross-coupling Reactions with Arylboronic Acids Catalyzed by Palladium and Nickel Complexes. Russian Journal of Organic Chemistry, 39(11).
DOI: 10.1023/b:rujo.0000013144.15578.2d